|
|
Article: Oncology nurses take the lead in providing novel therapy guidelines for multiple myeloma.(Editorial)(Editorial)
- Article from:
- Clinical Journal of Oncology Nursing
- Article date:
- June 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 Oncology Nursing Society. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
This supplement to the Clinical Journal of Oncology Nursing contains the first comprehensive guidelines for managing side effects from lenalidomide, thalidomide, and bortezomib used in the treatment of multiple myeloma (Bertolotti et al., 2008). Written by experienced specialty oncology nurses, the strategic summaries and specific recommendations provide a wonderful road map for all healthcare professionals. Increasing awareness about the range and potential severity of possible toxicities as well as summarizing state-of-the-art approaches to documenting and optimally managing the various side effects are important goals. Implementation of appropriate dose and schedule ...